EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension

J. Yorke, I. Armstrong, C. Harries (Manchester, Sheffield, United Kingdom)

Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Session: Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Session type: Thematic Poster Session
Number: 4089

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Yorke, I. Armstrong, C. Harries (Manchester, Sheffield, United Kingdom). EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension. Eur Respir J 2013; 42: Suppl. 57, 4089

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011



Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


The influence of psycho-social factors in the evolution of pulmonary hypertension patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006



Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Correlations between clinical variables and quality of life in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015


Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Quality of life and physical functioning in chronic thromboembolic pulmonary hypertension (CTEPH):  the impact of treatment
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015



Quality of life in patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2016; 48: 526-537
Year: 2016



Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Improving patient outcomes in pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 550-551
Year: 2015


Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015


Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension
Source: Eur Respir J, 50 (4) 1700465; 10.1183/13993003.00465-2017
Year: 2017



Patient rated WHO functional class and psychological distress are strongly associated with dyspnoea in pulmonary hypertension
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015

Quality of life in Russian patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008